Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System

• Register: ClinicalTrials.gov
• Last refreshed on: 13 June 2023
• Main ID: NCT04014933
• Date of registration: 03/07/2019
• Prospective Registration: No
• Primary sponsor: University of Zurich
• Public title: Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System LSFG Repro
• Scientific title: Prospective, Non-randomised, Non-controlled Study of Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
• Date of first enrolment: July 1, 2019
• Target sample size: 44
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT04014933
• Study type: Observational

Countries of recruitment

Switzerland

Contacts

• Name: Marc Töteberg-Harms, MD, FEBO
• Affiliation: UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland

Key inclusion & exclusion criteria

Inclusion Criteria:

- signed Patient Informed Consent form

- Be at least 18 years old

- Diagnosis of primary or secondary open-angle glaucoma or normal tension glaucoma or
healthy controls

Exclusion Criteria:

- Age < 18 years

- Inability to follow the procedures of the study, e.g. due to language problems,
psychological disorders, dementia, etc. of the participant.

- No vulnerable participants will be included in this study.



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Healthy

Normal Tension Glaucoma

Open Angle Glaucoma

Intervention(s)

Diagnostic Test: LASER SPECKLE FLOWGRAPHY

Primary Outcome(s)

Coefficients of variation (COV) [Time Frame: 1 month]

intraclass correlation coefficients (ICCs) [Time Frame: 1 month]

Secondary Outcome(s)

Cofounder [Time Frame: 1 month]

Secondary ID(s)

LSFG Repro

Source(s) of Monetary Support

Please refer to primary and secondary sponsors